Caplight Directory>Investors>Abingworth>Abingworth


Abingworth

Abingworth

London, Englandabingworth.com

Overview

Abingworth is a transatlantic life sciences investment firm that helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies . The firm invests across all stages of company development, including seed and early-stage, development stage, and clinical co-development .

Year Founded

1973

AUM

$2B

Portfolio Companies

27

Investments

CompanyDateStageLead
Cytospire TherapeuticsMay 2026Series ACo-investor
R1 TherapeuticsMar 2026Series ALead
Addition TherapeuticsDec 2025Series ACo-investor
Solve TherapeuticsNov 2025Early FundingCo-investor
Iambic TherapeuticsNov 2025Series CCo-investor
View all investments

Key People

Kurt von Emster

Managing Partner, Head Of Life Sciences

Tim Haines

Managing Director And Executive Partner

Ibraheem Mahmood

Operating Partner

Carlos Paya

Venture Partner

Natalie Mount

Venture Partner

Andrew Sinclair

Partner, Portfolio Manager

GLH Lloyd-Harris

Partner

Bali Muralidhar

Managing Partner, Chief Investment Officer

Diya Malhotra

Principal

Graham Mills

Principal

Jay Cui

Principal

Lucille Conroy

Principal

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded1973
AUM$2B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.